BEST SPAC I Acquisition (BSAAR) Cash & Equivalents (2025 - 2026)
BEST SPAC I Acquisition (BSAAR) posted quarterly Cash & Equivalents of $1.2 million for Q1 2026, down 9.53% quarter-over-quarter from $1.3 million in Q4 2025.
Powered by 
Analysis
BEST SPAC I Acquisition (BSAAR) Cash & Equivalents (2025 - 2026) Analysis & Trends
BEST SPAC I Acquisition's Cash & Equivalents history runs 2 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Cash & Equivalents changed N/A year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, changed N/A from the prior year.
- Cash & Equivalents for Q1 2026 stood at $1.2 million, down from $1.3 million in the prior quarter.
- The five-year high for Cash & Equivalents was $1.8 million in Q2 2025, with the low at $1.2 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | 250,000.00 |
| 3 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - | 54,503.00 |
| 4 | Fifth Era Acquisition Corp I | 657.23 Mn | 657.23 Mn | - | 157,686.00 |
| 5 | Andretti Acquisition | 656.30 Mn | 656.30 Mn | - | 225,380.00 |
| 6 | Oxley Bridge Acquisition | 652.74 Mn | 652.74 Mn | - | 729,941.00 |
| 7 | Drugs Made In America Acquisition | 647.83 Mn | 647.83 Mn | - | 174,974.00 |
| 8 | Launch Two Acquisition | 621.00 Mn | 621.00 Mn | - | 23,197.00 |
| 9 | Launch One Acquisition | 620.42 Mn | 620.42 Mn | - | 321,957.00 |
| 10 | BEST SPAC I Acquisition | 417,890.00 | 417,890.00 | - | 1.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Mn |
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.77 Mn |